PT1212315E - Novas calconas - Google Patents

Novas calconas

Info

Publication number
PT1212315E
PT1212315E PT00964042T PT00964042T PT1212315E PT 1212315 E PT1212315 E PT 1212315E PT 00964042 T PT00964042 T PT 00964042T PT 00964042 T PT00964042 T PT 00964042T PT 1212315 E PT1212315 E PT 1212315E
Authority
PT
Portugal
Prior art keywords
calconas
new
medicament
prevention
manufacture
Prior art date
Application number
PT00964042T
Other languages
English (en)
Portuguese (pt)
Inventor
Ezio Bompardelli
Piero Valenti
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of PT1212315E publication Critical patent/PT1212315E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82—Xanthenes
    • C07D311/84—Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • C07D311/86—Oxygen atoms, e.g. xanthones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT00964042T 1999-09-03 2000-08-28 Novas calconas PT1212315E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9920910.8A GB9920910D0 (en) 1999-09-03 1999-09-03 Novel chalcones

Publications (1)

Publication Number Publication Date
PT1212315E true PT1212315E (pt) 2003-08-29

Family

ID=10860346

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00964042T PT1212315E (pt) 1999-09-03 2000-08-28 Novas calconas

Country Status (21)

Country Link
US (1) US6620842B2 (https=)
EP (1) EP1212315B1 (https=)
JP (1) JP2003508527A (https=)
KR (1) KR100819576B1 (https=)
CN (1) CN1177843C (https=)
AT (1) ATE235483T1 (https=)
AU (1) AU776226B2 (https=)
CA (1) CA2382130A1 (https=)
CZ (1) CZ2002787A3 (https=)
DE (1) DE60001851T2 (https=)
DK (1) DK1212315T3 (https=)
ES (1) ES2193106T3 (https=)
GB (1) GB9920910D0 (https=)
HK (1) HK1043999B (https=)
HU (1) HUP0202579A3 (https=)
NO (1) NO20021049L (https=)
PL (1) PL353064A1 (https=)
PT (1) PT1212315E (https=)
RU (1) RU2252938C2 (https=)
SK (1) SK3112002A3 (https=)
WO (1) WO2001017988A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003234733B2 (en) 2002-04-17 2009-01-29 Cytokinetics, Inc. Compounds, compositions, and methods
US20030229136A1 (en) * 2002-04-18 2003-12-11 Nurulain Zaveri Novel flavanoids as chemotherapeutic, chemopreventive, and antiangiogenic agents
US7638554B2 (en) * 2002-04-18 2009-12-29 Sri International Flavanoids as chemotherapeutic, chemopreventive, and antiangiogenic agents
JP2005533119A (ja) 2002-07-17 2005-11-04 サイトキネティクス・インコーポレーテッド 化合物、組成物、及び方法
US6864264B1 (en) * 2002-08-20 2005-03-08 Gloria L. Anderson 1-adamantyl chalcones for the treatment of proliferative disorders
CN100336797C (zh) * 2005-08-19 2007-09-12 浙江大学 四取代查耳酮衍生物及制备方法和用途
WO2013127361A1 (en) * 2012-03-01 2013-09-06 The Hong Kong Polytechnic University Alkyne-, azide- and triazole-containing flavonoids as modulators for multidrug resistance in cancers

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990006921A1 (en) * 1988-12-21 1990-06-28 The Upjohn Company Antiatherosclerotic and antithrombotic 1-benzopyran-4-ones and 2-amino-1,3-benzoxazine-4-ones
US5023341A (en) * 1989-09-19 1991-06-11 Allergan, Inc. Compounds having a disubstituted acetylene moiety and retinoic acid-like biological activity
US4996230A (en) * 1990-02-16 1991-02-26 Eli Lilly And Company Leukotriene antagonists
WO1991017749A1 (en) * 1990-05-17 1991-11-28 Baylor College Of Medicine Growth inhibitors and methods of treating cancer and cell proliferative diseases
IT1271301B (it) 1994-12-20 1997-05-27 Indena Spa Calconi naturali e sintetici e loro esteri ad attivita' antiproliferativa nei tumori dell'utero,dell'ovaio e del seno e formulazioni che li contengono
US5525625A (en) * 1995-01-24 1996-06-11 Warner-Lambert Company 2-(2-Amino-3-methoxyphenyl)-4-oxo-4H-[1]benzopyran for treating proliferative disorders

Also Published As

Publication number Publication date
EP1212315B1 (en) 2003-03-26
GB9920910D0 (en) 1999-11-10
DK1212315T3 (da) 2003-06-23
ES2193106T3 (es) 2003-11-01
NO20021049D0 (no) 2002-03-01
DE60001851D1 (de) 2003-04-30
WO2001017988A1 (en) 2001-03-15
JP2003508527A (ja) 2003-03-04
US6620842B2 (en) 2003-09-16
HUP0202579A3 (en) 2003-07-28
CN1177843C (zh) 2004-12-01
CA2382130A1 (en) 2001-03-15
EP1212315A1 (en) 2002-06-12
SK3112002A3 (en) 2003-10-07
HK1043999B (en) 2003-08-15
KR20020031598A (ko) 2002-05-02
KR100819576B1 (ko) 2008-04-22
CN1371372A (zh) 2002-09-25
ATE235483T1 (de) 2003-04-15
NO20021049L (no) 2002-05-03
HUP0202579A2 (hu) 2002-11-28
AU7510900A (en) 2001-04-10
US20030055056A1 (en) 2003-03-20
DE60001851T2 (de) 2003-12-11
RU2252938C2 (ru) 2005-05-27
HK1043999A1 (en) 2002-10-04
AU776226B2 (en) 2004-09-02
CZ2002787A3 (cs) 2002-06-12
PL353064A1 (en) 2003-10-06

Similar Documents

Publication Publication Date Title
PL367682A1 (en) Dolastatin 10 derivatives
DK1233770T3 (da) Phosphonatforbindelser
TNSN05045A1 (en) Indole or benzimidazole derivatives for modulating ikappab kinase
MXPA04004674A (es) Ligados de los receptors de los canabinodies.
MY128659A (en) Novel aminodicarboxylic acid derivatives having pharmaceutical properties
MY146809A (en) Treatment and prevention of osteoporosis
DE69927050D1 (de) Biphenylverbindungen und biphenyl-analoge als intergrin-antagonisten
TR200101969T2 (tr) Enflamasyon tedavisi için sübstitüe edilmiş benzopiran analogları.
GB0225475D0 (en) Therapeutic agents
DE69908397D1 (de) Betulinsäure derivate zur behandlung von neuroektodermalen tumoren
MXPA04003087A (es) Derivados de cromano como ligados de 5-hidroxitriptamina-6.
MXPA04005886A (es) Derivados de azaindolilalquilamina como ligandos de 5-hidroxitirptamina-6.
NO20021050L (no) Nye derivater av flavoner, xantoner og kumariner
AP2000001898A0 (en) Vitronectin receptor antagonists
UA72948C2 (uk) Заміщені похідні фенілпіперазину, фармацевтична композиція та спосіб лікування афективних або неврологічних захворювань і розладів
DE69831409D1 (de) Chalcon-derivate mit antiproliferativer aktivität
PT1212315E (pt) Novas calconas
NO20014241D0 (no) C16-umettede FP-selektive prostaglandinanaloger
AP9801202A0 (en) Atropisomers of 3-heteroaryl-4(3H)-quinazolinones.
DE69917005D1 (de) Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung
BG104179A (en) Phanquinon administration for the treatment of the alzheimer's disease
TR200200278T2 (tr) Kalsilitik bileşimler
IL161116A0 (en) Use of irbesartan for the preparation of medicaments that are used to prevent or treat pulmonary hypertension
MXPA04000805A (es) Peptidos que tienen actividad antiangiogenica.
ATE346036T1 (de) Antiangiogene substanz zur behandlung von krebs, arthritis und netzhauterkrankungen